Pakistan is still struggling to raise humanitarian aid and provide access to the flood survivors with basic necessities such as food, shelter, clothing and medicines. The enormous calamity is likely to severely batter the economy, but equity market participants are keenly identifying sectors for future investments.

The government and other independent agencies are placing top priority to rehabilitating and providing medical facilities to flood victims. The World Health Organization (WHO) has also raised alarm over cases of acute diarrhea, skin diseases and cholera due to poor access to clean drinking water and sanitation conditions in the relief camps.

This will create additional demand for some of the leading local and multinational companies, such as Abbott, Glaxo Smith Kline and Searle, listed on the country’s bourses. These firms offer a broad product portfolio which could witness higher demand, especially in categories of anti-malarial and gastrointestinal medicines. The industry is believed to have the capacity to cater to the increased demand, but the challenge remains ensuring transparent and timely access to these medical supplies.

The pharmaceutical companies are also actively taking part in the rehabilitation efforts by generously contributing medicines for flood victims. These supplies have been made to different organizations that are engaged in setting up medical camps, while other donations in cash and kind have been offered to international relief agencies.